Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Devanand

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|October 19, 2012
Relapse risk after discontinuation of risperidone in Alzheimer's diseaseD P Devanand, Jacobo Mintzer, Susan K Schultz, et al.
Psychiatry Research|October 12, 2010
Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PETRachel Yehuda, Julia A Golier, Linda M Bierer, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2020
Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover StudyRachel Fremont, Masood Manoochehri, Nicole M Armstrong, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitationAyman Akil, Robert R Bies, Bruce G Pollock, et al.
Journal of Alzheimer'S Disease : JAD|October 7, 2017
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to DementiaMartin J Lan, R Todd Ogden, Dileep Kumar, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer diseaseD P Devanand, Ronald L Van Heertum, Lawrence S Kegeles, et al.
Neurology|March 14, 2007
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer diseaseD P Devanand, G Pradhaban, X Liu, et al.
Brain Stimulation|March 23, 2013
A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]Ziad Nahas, Baron Short, Carol Burns, et al.
Contemporary Clinical Trials|May 2, 2021
Development of novel measures for Alzheimer's disease prevention trials (NoMAD)Sophie A Bell, Hannah R Cohen, Seonjoo Lee, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 1, 2021
Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical TrialD P Devanand, Elizabeth Crocco, Brent P Forester, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|October 19, 2012
Relapse risk after discontinuation of risperidone in Alzheimer's diseaseD P Devanand, Jacobo Mintzer, Susan K Schultz, et al.
Psychiatry Research|October 12, 2010
Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PETRachel Yehuda, Julia A Golier, Linda M Bierer, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2020
Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover StudyRachel Fremont, Masood Manoochehri, Nicole M Armstrong, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitationAyman Akil, Robert R Bies, Bruce G Pollock, et al.
Journal of Alzheimer'S Disease : JAD|October 7, 2017
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to DementiaMartin J Lan, R Todd Ogden, Dileep Kumar, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer diseaseD P Devanand, Ronald L Van Heertum, Lawrence S Kegeles, et al.
Neurology|March 14, 2007
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer diseaseD P Devanand, G Pradhaban, X Liu, et al.
Brain Stimulation|March 23, 2013
A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]Ziad Nahas, Baron Short, Carol Burns, et al.
Contemporary Clinical Trials|May 2, 2021
Development of novel measures for Alzheimer's disease prevention trials (NoMAD)Sophie A Bell, Hannah R Cohen, Seonjoo Lee, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 1, 2021
Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical TrialD P Devanand, Elizabeth Crocco, Brent P Forester, et al.
Pageof 22